A previous study reported the interleukin-8 (IL-8) CSF contents could predict conversion to MS after CIS, suggesting that evaluation of the cytokines in CIS patients may provide useful information for predicting subsequent attacks (6). This evidence concerns the gene CXCL8 and myeloid sarcoma.